Literature DB >> 33942213

Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling.

Yiya Yang1, Yuting Lei1, Yumei Liang1, Shuangshuang Fu1, Congjun Yang1, Kanghan Liu1, Yinyin Chen2.   

Abstract

AIM: High glucose (HG) induces the production of transforming growth factor (TGF)-β and reactive oxygen species, which further activates JAK/STAT signaling and promotes the synthesis of matrix proteins, contributes to the pathophysiological processes of diabetic nephropathy. This study aims to investigate the protection role of vitamin D (VD) in the kidney in high glucose condition.
METHODS: Rat glomerular mesangial cells were cultured in high glucose medium, with or without VD or VD receptor (VDR) siRNAs treatment. The levels of TGF-β and fibronectin were detected by qRT-PCR, immunoblotting and enzyme-linked immunosorbent assay (ELISA). The levels of phosphorylated JAK2, STAT1 and STAT3, and JAK/STAT signaling downstream genes were examined by immunoblotting and qRT-PCR.
RESULTS: In rat glomerular mesangial cells, VD treatment can repress the tyrosine phosphorylation of JAK2, STAT1 and STAT3. VD inhibited TGF-β and fibronectin expression which was rescued by vitamin d receptor (VDR) siRNA and STATs inhibitor perficitinib. The JAK/STAT signaling downstream protein coding genes including SOCS1, SOCS3 and type IV collagen were repressed by VD. Meanwhile, the expression of non-coding RNAs such as miR-181a, miR-181b, was repressed by VD, and the expression of miR-34a and Let-7b was upregulated by VD.
CONCLUSION: Vitamin D (VD) treatment inhibits the function of HG on fibronectin production through regulating JAK/STAT pathway. These results provide direct evidences that VD protects glomerular mesangial cells from high glucose-induced injury through repressing JAK/STAT signaling, which has the potential for clinical DN treatment.

Entities:  

Keywords:  Glumerular cell; High glucose; JAK/STAT; Reactive oxygen species; Vitamin D

Year:  2021        PMID: 33942213     DOI: 10.1007/s11255-020-02728-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  35 in total

1.  Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.

Authors:  A Ceriello; A Morocutti; F Mercuri; L Quagliaro; M Moro; G Damante; G C Viberti
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

Review 2.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

Authors:  J W Baynes; S R Thorpe
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

3.  Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.

Authors:  I S Park; H Kiyomoto; S L Abboud; H E Abboud
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

4.  Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia.

Authors:  N A Wahab; K Harper; R M Mason
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 5.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Authors:  Giuseppe Remuzzi; Ariela Benigni; Andrea Remuzzi
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 6.  Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator.

Authors:  K Sharma; F N Ziyadeh
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

7.  Activation of the JAK-STAT pathway by reactive oxygen species.

Authors:  A R Simon; U Rai; B L Fanburg; B H Cochran
Journal:  Am J Physiol       Date:  1998-12

8.  Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

Authors:  M A Gall; P Rossing; P Skøtt; P Damsbo; A Vaag; K Bech; A Dejgaard; M Lauritzen; E Lauritzen; P Hougaard
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 9.  Role of the JAK/STAT signaling pathway in diabetic nephropathy.

Authors:  Mario B Marrero; Amy K Banes-Berceli; David M Stern; Douglas C Eaton
Journal:  Am J Physiol Renal Physiol       Date:  2006-04

Review 10.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.

Authors:  Francesco Paneni; Joshua A Beckman; Mark A Creager; Francesco Cosentino
Journal:  Eur Heart J       Date:  2013-05-02       Impact factor: 29.983

View more
  2 in total

1.  Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study.

Authors:  Tarek Atia; Mohammad Zahidul Iqbal; Hassan Fathy Ahmed; Hader I Sakr; M H Abdelzaher; Deaa Fekri Morsi; Mostafa E Metawee
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 2.  The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.

Authors:  Charlotte Delrue; Reinhart Speeckaert; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.